MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

ELV · NYSE

Elevance Health, Inc.

Health Care · Medical Specialities

Reference price$385.73As of Jul 28, 2026
Market capitalization$83.65B
52-week range$273.71–$436.24
S&P 500 portfolio weight0.13%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$393.00+1.9% vs. reference
Average$449.33+16.5% vs. reference
High$498.00+29.1% vs. reference
13 Buy6 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableSep 2026
Consensus EPS$4.9016 estimates
Expected range$4.51–$6.02Low to high EPS
Dec 2026$27.04Street EPS consensus
Dec 2027$29.34Street EPS consensus
Dec 2028$33.66Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+12.6% YoY$199B$177B
Operating income$6.71B$7.7B
Net income$5.66B$5.98B
Operating cash flow$4.29B$5.81B
Capital expenditures($1.12B)($1.26B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Centene Q2 Earnings Beat Estimates on Increasing Premiums

Zacks

UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures

Zacks

Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.